Evidence map›Paper›PMID 22623352›Full record

ArticleBiotechnology journal2012

A revisited folding reporter for quantitative assay of protein misfolding and aggregation in mammalian cells.

Simpson Gregoire, Inchan Kwon

Abstract read
In one paragraph

Article in Biotechnology journal, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Simpson GregoireDepartment of Chemical Engineering, University of Virginia, Charlottesville, VA 22904, USA.
Inchan Kwon

Funding

Exploiting Trans-Suppression to Arrest hSOD Aggregation in ALSR21NS069946 · NINDS · UNIVERSITY OF VIRGINIA · PI KWON, INCHAN · 2010 to 2011
$395k
NINDS NIH HHS R21 NS069946NINDS NIH HHS R21NS069946
6 · The paper itself

Abstract

Protein misfolding and aggregation play important roles in many physiological processes. These include pathological protein aggregation in neurodegenerative diseases and biopharmaceutical protein aggregation during production in mammalian cells. To develop a simple non-invasive assay for protein misfolding and aggregation in mammalian cells, the folding reporter green fluorescent protein (GFP) system, originally developed for bacterial cells, was evaluated. As a folding reporter, GFP was fused to the C-terminus of a panel of human copper/zinc superoxide dismutase (SOD1) mutants with varying misfolding/aggregation propensities. Flow cytometric analysis of transfected HEK293T and NSC-34 cells revealed that the mean fluorescence intensities of the cells expressing GFP fusion of SOD1 variants exhibited an inverse correlation with the misfolding/aggregation propensities of the four SOD1 variants. Our results support the hypothesis that the extent of misfolding/aggregation of a target protein in mammalian cells can be quantitatively estimated by measuring the mean fluorescence intensity of the cells expressing GFP fusion. The assay method developed herein will facilitate the understanding of aggregation process of SOD1 variants and the identification of aggregation inhibitors. The method also has great promise for misfolding/aggregation studies of other proteins in mammalian cells.

Indexed as

BiotechnologyFlow CytometryGreen Fluorescent ProteinsHEK293 CellsHumansMicroscopy, FluorescenceMultiprotein ComplexesMutationPromoter Regions, GeneticProtein FoldingRecombinant Fusion ProteinsSuperoxide DismutaseTransfectionGreen Fluorescent ProteinsMultiprotein ComplexesRecombinant Fusion ProteinsSuperoxide Dismutase

Identifiers

PMID22623352
PMCPMC3517142

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.